Anixa Biosciences, Inc. (ANIX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Anixa Biosciences, Inc. (ANIX)
Go deeper and ask any question about ANIX
Company Performance
Current Price
as of Sep 13, 2024$3.35
P/E Ratio
N/A
Market Cap
$107.8M
Description
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Metrics
Overview
- HQSan Jose, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerANIX
- Price$3.35+0.90%
Trading Information
- Market Cap$107.80M
- Float94.97%
- Average Daily Volume (1m)61,398
- Average Daily Volume (3m)98,986
- EPS-$0.39
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$3.28M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$3.59M
- EV$84.83M
- EV/RevenueN/A
- P/EN/A
- P/SN/A